直接面向患者的数字健康项目促进肺癌筛查:一项随机临床试验
该随机临床试验在美国东南部2个学术健康系统纳入1333名符合肺癌筛查标准的50至77岁个体,比较mPATH-Lung数字健康项目与增强常规护理对16周内完成胸部CT的影响。mPATH-Lung组胸部CT完成率高于对照组(24.5% vs 17.0%;OR 1.6;95%CI 1.2-2.1)。作者建议未来研究应在多样人群和医疗环境中评估数字肺癌筛查干预的可及性和有效性。
要点
- mPATH-Lung组16周内胸部CT完成率为24.5%(164/669),对照组为17.0%(113/664),OR 1.6(95%CI 1.2-2.1)。
- 完成筛查CT者中,假阳性结果在mPATH-Lung组占12.7%(19/150),对照组占8.4%(8/95)。
- 侵入性操作在干预组占2.0%(3/150),对照组占1.1%(1/95),均无并发症。
核心结论
- 与增强常规护理相比,直接面向患者的数字健康干预提高了肺癌筛查率。
- 作者建议未来研究应在多样人群和医疗环境中评估数字肺癌筛查干预的可及性和有效性。
研究设计与样本
- 随机临床试验,于2022年4月18日至2023年5月30日在美国东南部2个学术健康系统纳入符合美国联邦医疗保险与医疗补助服务中心肺癌筛查标准的50至77岁个体,末次随访日期为2024年9月30日。
- 共1333名参与者按1:1随机分组:mPATH-Lung数字健康项目组669人,增强常规护理组664人。
- mPATH-Lung项目在临床就诊之外提供简短决策辅助和预约筛查选项;增强常规护理组患者被告知肺癌筛查资格并建议与初级保健临床医生讨论。
- 主要结局为16周内完成任何胸部CT;次要结局包括筛查决策、过程指标、临床结局、筛查危害和实施结局。
主要发现
- mPATH-Lung组胸部CT完成率高于对照组(24.5%[164/669] vs 17.0%[113/664];OR 1.6;95%CI 1.2-2.1)。
- 完成筛查CT者中,假阳性结果在mPATH-Lung组为12.7%(19/150),对照组为8.4%(8/95)。
- 侵入性操作在mPATH-Lung组为2.0%(3/150),对照组为1.1%(1/95),均无并发症。
- 参与者平均年龄60.7岁(SD 6.8岁);864人(65%)为女性;232人(17%)为黑人,1054人(79%)为非西班牙裔白人;621人(47%)有商业保险,595人(45%)有公共保险。
- 共向26909名电子健康记录中有吸烟史者发送电子邀请,3267人完成网站资格问题,1333人被判定符合资格并入选。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者在结论中提出未来研究应在多样人群和医疗环境中评估数字肺癌筛查干预的可及性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Screening chest computed tomography (CT) scans reduce lung cancer mortality in high-risk individuals, but less than 20% of eligible individuals are screened in the US. OBJECTIVE: To determine whether a direct-to-patient digital health program increases lung cancer screening. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial enrolling individuals aged 50 to 77 years who met Centers for Medicare & Medicaid Services criteria for lung cancer screening between April 18, 2022, and May 30, 2023, at 2 academic health systems in the southeastern US. The date of last follow-up was September 30, 2024. INTERVENTIONS: Participants were randomized 1:1 to the mPATH-Lung program, a digital health program delivered outside a clinical visit that included a brief decision aid and option to request a screening appointment (n = 669) or enhanced usual care, in which patients were notified of their lung cancer screening eligibility and advised to speak with their primary care clinician (n = 664). MAIN OUTCOMES AND MEASURES: The primary outcome was completion of any chest CT within 16 weeks. Secondary outcomes included screening decisions, process measures (screening visits, CT scans ordered), clinical outcomes (lung cancer screening results, lung cancers diagnosed), screening harms, and implementation outcomes. RESULTS: Electronic invitations were sent to 26 909 individuals with a smoking history in their electronic health record; 3267 completed website eligibility questions and 1333 were deemed eligible and enrolled. The mean age was 60.7 years (SD, 6.8 years); 864 (65%) were female; 232 (17%) were Black and 1054 (79%) were non-Hispanic White; and 621 (47%) had commercial insurance and 595 (45%) had public insurance. Chest CT completion was higher in the mPATH-Lung group than in controls (24.5% [164/669] vs 17.0% [113/664]; odds ratio, 1.6; 95% CI, 1.2-2.1). Among patients who completed screening CT, false-positive results occurred in 12.7% (19/150) of mPATH-Lung participants and 8.4% (8/95) of controls. Invasive procedures were performed in 2.0% (3/150) in the intervention group and 1.1% (1/95) in the control group, with no complications. CONCLUSIONS AND RELEVANCE: Compared with enhanced usual care, a direct-to-patient digital health intervention increased rates of lung cancer screening. Future research should assess the reach and effectiveness of digital lung cancer screening interventions across diverse populations and health care settings. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04083859.
引用
- Miller DP, Snavely AC, Dharod A, et al. A Direct-to-Patient Digital Health Program for Lung Cancer Screening: A Randomized Clinical Trial. JAMA. 2025. PMID: 41114973. doi:10.1001/jama.2025.17281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。